Interventional Cardiology Market Research Report - Forecast till 2027

Interventional Cardiology Market: By Type (Stents (Drug-Eluting Stents, Bare Metal Stents and Bioresorbable Vascular Scaffolds), Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters (Balloon Catheters and Guiding Catheters), Plaque Modification Devices, Coronary Guidewires, and Accessories), End-User (Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Others), Region (Americas, Europe, Asia-Pacific, Middle East & Africa)- Forecast to 2027

ID: MRFR/HC/7263-HCR | February, 2021 | Region : Global

Table of Contents

1. EXECUTIVE SUMMARY

1.1. Market Attractiveness Analysis

1.1.1. Global Interventional Cardiology Market, by Type

1.1.2. Global Interventional Cardiology Market, by End User

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Breakdown of Primary Respondents

3.5. Forecasting Techniques

3.6. Research Methodology for Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.2.1. R&D and Designing

5.2.2. Manufacturing

5.2.3. Distribution and Sales

5.2.4. Post Sales Services

6. GLOBAL INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE

6.1. Overview

6.2. Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1. Drug Eluting Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2. Bare Metal Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.3. Bioresorbable Vascular Scaffolds

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. PTCA Catheters

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.1. Balloon Catheters

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.2. Guiding Catheters

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4. Plaque Modification Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5. Coronary Guidewires

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6. Accessories

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL INTERVENTIONAL CARDIOLOGY MARKET, BY END USER

7.1. Overview

7.2. Hospitals

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Cardiac Catheterization Laboratories

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4. Ambulatory Surgical Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL INTERVENTIONAL CARDIOLOGY MARKET, BY REGION

8.1. Overview

8.2. Americas

8.2.1. North America

8.2.1.1. US

8.2.1.2. Canada

8.2.2. Latin America

8.3. Europe

8.3.1. Western Europe

8.3.1.1. Germany

8.3.1.2. France

8.3.1.3. Italy

8.3.1.4. Spain

8.3.1.5. UK

8.3.1.6. Rest of Western Europe

8.3.2. Eastern Europe

8.4. Asia-Pacific

8.4.1. Japan

8.4.2. China

8.4.3. India

8.4.4. Australia

8.4.5. South Korea

8.4.6. Rest of Asia-Pacific

8.5. Middle East & Africa

8.5.1. Middle East

8.5.2. Africa

9. COMPANY LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Company Share Analysis

9.4. Competitor Dashboard

9.5. Major Growth Strategy in the Global Interventional Cardiology Market

9.6. Competitive Benchmarking

9.7. Leading Player in terms of Number of Developments in the Global Interventional Cardiology Market

9.8. Key Developments & Growth Strategies

9.8.1. New Product Launch

9.8.2. Merger & Acquisition

9.8.3. Joint Ventures

9.9. Major Players Financial Matrix & Market Ratio

9.9.1. Sales & Operating Income 2020

9.9.2. Major Players R&D Expenditure 2020

9.9.3. Major Players Capital Market Ratio

10. COMPANY PROFILES

10.1. ABIOMED

10.1.1. Company Overview

10.1.2. Products/Services Offered

10.1.3. Financial Overview

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. Abbott

10.3. ACIST Medical Systems, Inc.

10.4. B. Braun Melsungen AG

10.5. BD

10.6. Biosense Webster, Inc

10.7. Biotronik SE & Co. KG

10.8. Boston Scientific Corporation

10.9. Cardinal Health

10.10. Cook Medical

10.11. Edwards Lifesciences Corporation

10.12. GE Healthcare

10.13. Koninklijke Philips N.V.

10.14. Life Vascular Devices Biotech S.L.

10.15. Medtronic

10.16. Merit Medical Systems, Inc

10.17. Terumo Corporation

10.18. W. L. Gore & Associates, Inc.

10.19. Others

11. APPENDIX

11.1. References

11.2. Related Reports


LIST OF TABLES

TABLE 1 GLOBAL INTERVENTIONAL CARDIOLOGY MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL INTERVENTIONAL CARDIOLOGY MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 5 GLOBAL INTERVENTIONAL CARDIOLOGY MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 6 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 7 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 8 US: INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 9 US: INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 10 CANADA: INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 11 CANADA: INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 12 LATIN AMERICA: INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 13 LATIN AMERICA: INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 14 EUROPE: INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 15 EUROPE: INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 16 WESTERN EUROPE: INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 17 WESTERN EUROPE: INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 18 EASTERN EUROPE: INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 19 EASTERN EUROPE: INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 20 ASIA-PACIFIC: INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 21 ASIA-PACIFIC: INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA: INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA: INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2020-2027 (USD MILLION)


LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL INTERVENTIONAL CARDIOLOGY MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL INTERVENTIONAL CARDIOLOGY MARKET

FIGURE 4 GLOBAL INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY TYPE, 2020 (%)

FIGURE 5 GLOBAL INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY END USER, 2020 (%)

FIGURE 6 GLOBAL INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY REGION, 2020 (%)

FIGURE 7 AMERICAS: INTERVENTIONAL CARDIOLOGY MARKET SHARE BY REGION, 2020 (%)

FIGURE 8 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 9 EUROPE: INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY REGION, 2020 (%)

FIGURE 10 WESTERN EUROPE: INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 11 ASIA-PACIFIC: INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 MIDDLE EAST & AFRICA: INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 GLOBAL INTERVENTIONAL CARDIOLOGY MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 14 ABIOMED: KEY FINANCIALS

FIGURE 15 ABIOMED: SEGMENTAL REVENUE

FIGURE 16 ABIOMED: REGIONAL REVENUE

FIGURE 17 ABBOTT: KEY FINANCIALS

FIGURE 18 ABBOTT: SEGMENTAL REVENUE

FIGURE 19 ABBOTT: REGIONAL REVENUE

FIGURE 20 ACIST MEDICAL SYSTEMS, INC.: KEY FINANCIALS

FIGURE 21 ACIST MEDICAL SYSTEMS, INC.: SEGMENTAL REVENUE

FIGURE 22 ACIST MEDICAL SYSTEMS, INC.: REGIONAL REVENUE

FIGURE 23 B. BRAUN MELSUNGEN AG: KEY FINANCIALS

FIGURE 24 B. BRAUN MELSUNGEN AG: SEGMENTAL REVENUE

FIGURE 25 B. BRAUN MELSUNGEN AG: REGIONAL REVENUE

FIGURE 26 BD: KEY FINANCIALS

FIGURE 27 BD: SEGMENTAL REVENUE

FIGURE 28 BD: REGIONAL REVENUE

FIGURE 29 BIOSENSE WEBSTER, INC: KEY FINANCIALS

FIGURE 30 BIOSENSE WEBSTER, INC: SEGMENTAL REVENUE

FIGURE 31 BIOSENSE WEBSTER, INC: REGIONAL REVENUE

FIGURE 32 BIOTRONIK SE & CO. KG: KEY FINANCIALS

FIGURE 33 BIOTRONIK SE & CO. KG: SEGMENTAL REVENUE

FIGURE 34 BIOTRONIK SE & CO. KG: REGIONAL REVENUE

FIGURE 35 BOSTON SCIENTIFIC CORPORATION.: KEY FINANCIALS

FIGURE 36 BOSTON SCIENTIFIC CORPORATION.: SEGMENTAL REVENUE

FIGURE 37 BOSTON SCIENTIFIC CORPORATION.: REGIONAL REVENUE

FIGURE 38 CARDINAL HEALTH: KEY FINANCIALS

FIGURE 39 CARDINAL HEALTH: SEGMENTAL REVENUE

FIGURE 40 CARDINAL HEALTH: REGIONAL REVENUE

FIGURE 41 COOK MEDICAL: KEY FINANCIALS

FIGURE 42 COOK MEDICAL: SEGMENTAL REVENUE

FIGURE 43 COOK MEDICAL: REGIONAL REVENUE

FIGURE 44 EDWARDS LIFESCIENCES CORPORATION: KEY FINANCIALS

FIGURE 45 EDWARDS LIFESCIENCES CORPORATION: SEGMENTAL REVENUE

FIGURE 46 EDWARDS LIFESCIENCES CORPORATION: REGIONAL REVENUE

FIGURE 47 GE HEALTHCARE: KEY FINANCIALS

FIGURE 48 GE HEALTHCARE: SEGMENTAL REVENUE

FIGURE 49 GE HEALTHCARE: REGIONAL REVENUE

FIGURE 50 KONINKLIJKE PHILIPS N.V.: KEY FINANCIALS

FIGURE 51 KONINKLIJKE PHILIPS N.V.: SEGMENTAL REVENUE

FIGURE 52 KONINKLIJKE PHILIPS N.V.: REGIONAL REVENUE

FIGURE 53 LIFE VASCULAR DEVICES BIOTECH S.L.: KEY FINANCIALS

FIGURE 54 LIFE VASCULAR DEVICES BIOTECH S.L.: SEGMENTAL REVENUE

FIGURE 55 LIFE VASCULAR DEVICES BIOTECH S.L.: REGIONAL REVENUE

FIGURE 56 MEDTRONIC: KEY FINANCIALS

FIGURE 57 MEDTRONIC: SEGMENTAL REVENUE

FIGURE 58 MEDTRONIC: REGIONAL REVENUE

FIGURE 59 MERIT MEDICAL SYSTEMS, INC: KEY FINANCIALS

FIGURE 60 MERIT MEDICAL SYSTEMS, INC: SEGMENTAL REVENUE

FIGURE 61 MERIT MEDICAL SYSTEMS, INC: REGIONAL REVENUE

FIGURE 62 TERUMO CORPORATION: KEY FINANCIALS

FIGURE 63 TERUMO CORPORATION: SEGMENTAL REVENUE

FIGURE 64 TERUMO CORPORATION: REGIONAL REVENUE

FIGURE 65 W. L. GORE & ASSOCIATES, INC.: KEY FINANCIALS

FIGURE 66 W. L. GORE & ASSOCIATES, INC.: SEGMENTAL REVENUE

FIGURE 67 W. L. GORE & ASSOCIATES, INC.: REGIONAL REVENUE



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.